Imperial Petroleum (IMPP) Q4 Earnings Surge 250% YoY to $0.35 EPS on Strong Tanker UtilizationMarch 7, 2026
Biogen’s new Alzheimer’s drug to raise Medicare costs (NASDAQ:BIIB) Markets May 14, 2023 zimmytws Leqembi, the brand new Alzheimer’s remedy developed by Biogen (NASDAQ:BIIB) and Eisai (OTCPK:ESALF) (OTCPK:ESAIY), might add $2B – $5B…
Lilly posts Phase 3 data to compare Alzheimer’s drug vs. Biogen’s (NYSE:LLY) Markets December 1, 2022 koto_feja Eli Lilly (NYSE:LLY) shared information from a Part 3 trial for its Alzheimer’s illness donanemab, evaluating its efficiency in…
How might the CMS decision on Biogen’s Aduhelm impact other Alzheimer’s candidates? Markets April 10, 2022 selvanegra/iStock through Getty Photos Regardless of the Facilities for Medicare & Medicaid Providers’ (CMS) determination on April 7 to severely…
